SCHEMBL22019956

SCHEMBL22019956

O=CNc1c2c(nc3c1CCC3)CCC2

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
USP2 O75604 1/20 0.47
ACHE P22303 7/20 0.46
KDM4E B2RXH2 3/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MAPK1 P28482 1/20 0.43
BPTF Q12830 1/20 0.43
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
HRH3 Q9Y5N1 1/20 0.37
BCHE P06276 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20783124 0.72 NLRP3 (0.33)
SCHEMBL22705084 0.72
SCHEMBL22021561 0.71 CYP1A2 (0.52) CYP1A2GAANPSR1USP2ACHE
SCHEMBL20635326 0.71 NLRP3 (0.42) SMN1; SMN2
SCHEMBL20681381 0.71 GAA (0.61) CYP1A2GAANPSR1USP2ACHE
SCHEMBL21963250 0.69 GAA (0.64) CYP1A2GAANPSR1USP2ACHE
SCHEMBL22019806 0.69 GAA (0.59) CYP1A2GAANPSR1USP2ACHE
SCHEMBL18366286 0.63 GAA (0.33) GAAKDM4EKMT2ATSHR
SCHEMBL20761734 0.62 ACHE (0.54) CYP1A2GAANPSR1USP2ACHE
SCHEMBL21963258 0.62 ACHE (0.54) CYP1A2GAANPSR1USP2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed